Growth Metrics

Nexalin Technology (NXL) Payables (2021 - 2026)

Nexalin Technology's quarterly Payables came in at $168099.0 in Q1 2026, down 7.33% year-on-year from $181394.0 in Q1 2025, and down 31.27% quarter-over-quarter from $244579.0 in Q4 2025.

Nexalin Technology has reported Payables for 6 years, with the latest figure at $168099.0 in Q1 2026.

  • For the quarter ending Q1 2026, Payables fell 7.33% year-over-year to $168099.0; the trailing twelve-month figure through Mar 2026 stood at $168099.0 (down 7.33% YoY), and the FY2025 full-year result was $244579.0, up 56.83% from the prior year.
  • Payables for Q1 2026 stood at $168099.0, down from $244579.0 in the prior quarter.
  • The five-year high for Payables was $1.3 million in Q3 2022, with the low at $67493.0 in Q3 2025.
  • Average Payables over 5 years is $383019.1, with a median of $181394.0 recorded in 2025.
  • Year-over-year, Payables sank 86.23% in 2023 and soared 176.09% in 2025.
  • Tracing NXL's Payables over 5 years: stood at $1.2 million in 2022, then slumped by 86.23% to $159534.0 in 2023, then dropped by 2.25% to $155949.0 in 2024, then soared by 56.83% to $244579.0 in 2025, then slumped by 31.27% to $168099.0 in 2026.
  • The last three Payables figures came in at $168099.0 (Q1 2026), $244579.0 (Q4 2025), and $67493.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.78 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.74 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.42 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 457.70 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 168,099.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 168,099.00
Dec 31, 2025 244,579.00
Sep 30, 2025 67,493.00
Jun 30, 2025 240,580.00
Mar 31, 2025 181,394.00
Dec 31, 2024 155,949.00
Sep 30, 2024 166,542.00
Jun 30, 2024 87,138.00
Mar 31, 2024 151,510.00
Dec 31, 2023 159,534.00
Sep 30, 2023 572,549.00
Jun 30, 2023 548,501.00
Mar 31, 2023 554,758.00
Dec 31, 2022 1.16 Mn
Sep 30, 2022 1.29 Mn
Dec 31, 2021 1.34 Mn